The effect of diabetes mellitus on endocrine and reproductive function

Proceedings of the Society for Experimental Biology and Medicine

Volumn 214, Issue 1, 1997, Pages 1-11

  Steger, Richard W ^a   Rabe, Milagros B ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GONADORELIN; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; ISOPRENALINE; LIOTHYRONINE; LUTEINIZING HORMONE; NORADRENALIN; PHORBOL DIBUTYRATE; PROLACTIN; THYROXINE;

ADRENAL CORTEX; ADRENAL MEDULLA; ALLOXAN DIABETES MELLITUS; AMENORRHEA; ANIMAL MODEL; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; IMPOTENCE; MALE; NONHUMAN; RAT; REPRODUCTION; SHORT SURVEY; SPERMATOGENESIS; STREPTOZOCIN DIABETES;

EID: 0031033827     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-214-44064     Document Type: Short Survey

References (164)

1. Hansen AP, Johansen K. Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon, and growth hormone in normals and juvenile diabetics. Diabetologia 6:27-33, 1970.
2. Dieguez C, Page MD, Scanlon MF. Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol (Oxf) 28:109-143, 1988.
3. Tamborlane WV, Hintz RL, Bergman M, Genel M, Felig P, Sherwin RS. Insulin infusion pump treatment of diabetics. Influence of improved metabolic control on plasma somatomedin levels. N Engl J Med 305:303, 1981.
4. Hansen AP. Abnormal serum growth hormone response to exercise in juvenile diabetics. J Clin Invest 49:1467-1478, 1970.
5. Johansen K, Hansen AP. Diurnal serum growth hormone levels in poorly and well-controlled juvenile diabetics. Diabetes 20:239-245, 1971.
6. Holly JMP, Amiel SA, Sandhu RR, Reehs LH, Wass JAH. The role of growth hormone in diabetes mellitus. J Endocrinol 118:353-364, 1988.
7. Sönksen PH, Russell-Jones D, Jones RH. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future? Horm Res 40:68-79, 1993.
8. Tan K, Baxter RC. Serum insulin-like growth factor 1 levels in adult diabetic patients. J Clin Endocrinol Metab 63:651-655, 1986.
9. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press GM, Tambourlane WV. Effects of diabetes and its control on insulin-like growth factor in young subjects with type 1 diabetes. Diabetes 33:1175-1179, 1984.
10. Grecu EO, Walter RM. Human growth hormone responses to a fall in plasma glucose in normal and diabetic subjects. Diabetologia 24:136-137, 1983.
11. Daughaday WH, Phillips LC, Mueller MC. The effect of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:1214-1219, 1976.
12. Harrison HE, Robinson TE. Impaired growth hormone secretion in streptozotocin diabetic rats. Horm Metab Res 12:556, 1980.
13. Tannenbaum GS, Coll E, Gurd W, Wanamaker L. Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. I. Longitudinal profiles of plasma growth hormone, insulin and glucose. Endocrinology 109:1872-1879, 1981.
14. Tannenbaum GS, Colle E, Gurd W, Wanamaker L. Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin. Endocrinology 108:76-82, 1981.
15. Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW Jr., Gilbert JM Jr., Berelowitz M. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: A combined defect of hypothalamic somatostatin and GH-releasing factor. Endocrinology 126:53-61, 1990.
16. Joanny P, Peyre G, Steinber J, Guillaume V, Pesce G, Becquet D, Oliver C. Effect of diabetes on in vivo and in vitro hypothalamic somatostatin release. Neuroendocrinology 55:485-491, 1992.
17. Ndon JA, Giustina A, Wehrenberg WB. Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 1. Studies in streptozotocin-induced diabetic rats. Neuroendocrinology 55:500-505, 1992.
18. Ndon JA, Giustina A, Wehrenberg WB. Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 2. Studies in spontaneously diabetic BB Worcester rats. Neuroendocrinology 55:506-511, 1992.
19. Schaper NC, Verhoeff AJ, Roelse H, Reitsma WD, Sluiter WJ, Doorenbos H. The pituitary response to somatostatin during growth hormone-releasing hormone administration in type I diabetes mellitus. Acta Endocrinol (Copenh) 122(Suppl 2):40-44.
20. Cohen RM, Abplanalp WA. Resistance of growth hormone secretion to somatostatin in men with type I diabetes mellitus. Diabetes 40:1251-1258, 1991.
21. Welsh JB, Szabo M. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats. Endocrinology 123:2230-2234, 1988.
22. Sheppard MS, Eatock BA, Bala RM. Altered release of growth hormone from dispersed adenohypophsial cells of streptozotocin diabetic rats. I. Effects of growth hormone-releasing factor and somatostatin. Can J Physiol Pharmacol 67:1315-1320, 1989.
23. Pesce G, Guillaume V, Dutour A, Dadoun F, Joanny P, Steinberg J, Oliver C. Effect of streptozotocin-induced diabetes on somatostatin receptors in the anterior pituitary, hypothalamus and cerebral cortex of the male rat. Life Sci 54:1927-1933, 1994.
24. Katakami H, Berelowitz M, Marbach M, Frohman LA. Modulation of somatostatin binding to rat pituitary membranes by exogenously administered growth hormone. Endocrinology 117:557, 1985.
25. Patel YC, Cameron DP, Bankier A, Malaisse-Lagae F, Ravazzola M, Studer P, Orci L. Changes in somatostatin concentration in pancreas and other tissues of streptozotocin diabetic rats. Endocrinology 103:917-923, 1978.
26. Papachristou DN, Pham K, Zingg HH, Patel YC. Tissue-specific alterations in somatostatin mRNA accumulation in streptozotocin-diabetic rats. Diabetes 38:752-757, 1989.
27. Richardson SB, Twente S. Somatostatin release from dispersed hypothalamic cells: Effects of diabetes. Diabetologia 30:893-898, 1987.
28. Patel YC, Wheatley T, Zingg HH. Increased blood somatostatin concentration in streptozotocin diabetic rats. Life Sci 27:1563-1570, 1980.
29. Giustina A, Bossoni S, Cimino A, Pizzocolo G, Romanelli G, Wehrenberg WB. Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. J Clin Endocrinol Metab 71:1486-1490, 1990.
30. Asplin CM, Faria AC, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:239-245, 1989.
31. Schaper NC, Tamsma JT, Sluiter WJ, Roelse H, Reitsma WD, Doorenbos H. Growth hormone autoregulation in type I diabetes mellitus. Acta Endocrinol (Copenh) 122(Suppl 2):32-39, 1990.
32. Ismail IS, Scanlon MF, Peters JR. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: Evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Clin Endocrinol (Oxf) 38:149-157, 1993.
33. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. Somatimedin C mediates growth hormone feedback by effects both on the hypothalamus and the pituitary. Science 212:1279-1281, 1981.
34. Pietschmann P, Schernthaner G, Prskavec F, Gisinger C, Freyler H. No evidence for increased growth hormone response to growth hormone-releasing factor in patients with diabetic retinopathy. Diabetes 36:159-162, 1987.
35. Krassowski J, Felber JP, Rogala H, Jeske W, Zgliczynski S. Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus. Acta Endocrinol 117:225-229, 1988.
36. Richards NT, Wood SM, Christofides ND, Bhuttcharji SC, Bloom SR. Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF (1-44)] in type 2 (non-insulin-dependent) diabetes. Diabetologia 27:529-534, 1984.
37. Williams T, Berelowitz M, Joffee SN, Thorner MO, Rivier J, Vale W, Frohman LA. Impaired growth hormone response to growth hormone-releasing hormone in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311:1403-1407, 1984.
38. Locatelli V, Miyoshi H, Bestetti G, Rossi G, Muller EE. Effect of growth hormone-releasing stimuli in streptozotocin diabetic rats. Brain Res 341:35-40, 1985.
39. Serri O, Brazeau P. Growth hormone responsiveness in vivo and in vitro to growth hormone-releasing factor in the spontaneously diabetic BB Wistar rat. Neuroendocrinology 46:162-166, 1987.
40. Boujon CE, Bestetti GE, Abramo F, Locatelli V, Rossi GL. The reduction of circulating growth hormone and prolactin in streptozocin-induced diabetic male rats is possibly caused by hypothalamic rather than pituitary changes. J Endocrinol 145:19-26, 1995.
41. Arends J, Wagner M-L, Willms B. Cholineric muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in typ I diabetic subjects. J Clin Endocrinol Metab 66:389-393, 1988.
42. Gray RS, Seth DQ, Herd R, Brown NS, Clark BF. Prevalence of subclinical thyroidal failure in insulin dependent diabetes. J Clin Endocrinol Metab 50:1034-1037, 1980.
43. Pittman CS, Suda AK, Chambers JB, McDaniel HG, Ray GR, Preston BK. Abnormalities of thyroid hormone turnover in patients with diabetes mellitus before and after insulin treatment. J Clin Endocrinol Metab 48:854-860, 1979.
44. Pittman CS, Suda AK, Chambers JB, Ray GR. Impaired 3,5,3′ T3 production in diabetic patients. Metabolism 28:333-338, 1979.
45. Alexander CM, Kaptein EM, Lum SMC, Spencer CA, Kumar D, Nicoloff JT. Pattern of recovery of thyroid hormone associated with treatment of diabetes mellitus. J Clin Endocrinol Metab 54:362-366, 1982.
46. Fraley DS, Totten RS. An autopsy study of endocrine organ changes in diabetes mellitus. Metabolism 17:896-900, 1968.
47. Kumaresan P, Turner CW. Effect of insulin upon thyroxine secretion rate of female rats. Proc Soc Exp Biol Med 121:752-554, 1966.
48. Wilber JF, Banerji A, Prassad C, Mori M. Alterations in hypothalamic pituitary-thyroid regulation produced by diabetes mellitus. Life Sci 28:1757-1763, 1981.
49. Jolin T, Gonzales C. Thyroid iodine metabolism in streptozotocin diabetic rats. Endocrinologica 88:506-515, 1978.
50. Chopra IJ, Wirsienga W, Frank H. Alterations in hepatic monodeiodination of iodothyronines in the diabetic rat. Life Sci 28:1765-1776, 1981.
51. Mitsuma T, Nogimori T. Effects of streptozotocin-induced diabetes mellitus on hypothalamic-pituitary thyroid axis in rats. Endocrinol Jap 29:695-700, 1982.
52. Gonzales C, Montoya E, Jolin T. Effect of streptozotocin diabetes on the hypothalamic-pituitary-thyroid axis in the rat. Endocrinology 107:2099-2103, 1980.
53. Bestetti GE, Reymond MJ, Perrin IV, Kniel PC, Lemarchaand-Beraud T, Rossi GL. Thyroid and pituitary secretory disorders in streptozotocin-induced rats are associated with severe structural changes of these glands. Virchows Archiv B 53:69-78, 1987.
54. Bestetti GE, Reymond MJ, Boujon CE, Lemarchand-Beraud T and Rossi GL. Functional and morphological aspects of impaired TRH release by medial basal hypothalamus of STZ-induced diabetic rats. Diabetes 38:1351-1356, 1989.
55. Rondeel JMM, De Greef WJ, Heide R, Visser TJ. Hypothalamohypophysial-thyroid axis in streptozotocin-induced diabetes. Endocrinology 130:216-220, 1992.
56. Bestetti G, Rossi GL. Hypothalamic lesions in rats with long-term streptozotocin-induced diabetes mellitus. Acta Neuropathologica 52:119-127, 1980.
57. Hefco E, KrulichL, Aschenbrenner JE. Effect of hypothalamic deafferentation on the secretion of thyrotropin during thyroid blockade and exposure to cold in the rat. Endocrinology 97:1185-1195, 1975.
58. Morley JE, Brammer GL, Sharp B, Yamada T, Yuwiler A, Hershman JM. Neurotransmitter control of hypothalamic-pituitary-thyroid function in rats. Eur J Pharmacol 70:263-271, 1981.
59. Henley WN, Bellush LL. Streptozotocin-induced decreases in serotonin turnover are prevented by thyroidectomy. Neuroendocrinology 56:354-363, 1992.
60. Rossi GL, Bestetti GE, Tontis DK, Varini M. Reverse hemolytic plaque assay study of luteinizing and follicle-stimulating hormone and thyrotropin secretion in diabetic rat pituitary glands. Diabetes 38:1301-1306, 1989.
61. Chamras H, Hershman JM. Effect of diabetes mellitus on thyrotropin release from isolated rat thyrotrophs. Am J Med Sci 300:16-21, 1990.
62. Ortiz-Caro J, Jolin T. Secretion and metabolic clearance rates of thyroxin and triiodothyronine in streptozotocin diabetic rats. Acta Endocrinol 110:395-400, 1985.
63. Balsam A, Inbar SH, Sexton FC. The influence of fasting, diabetes and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest 62:415-424, 1978.
64. Bagchi N, Brown TR, Shivers B, Lucas S, Mack RE. Decreased thyroidal response to thyrotropin in diabetic mice. Endocrinology 109:1428-1432, 1981.
65. Ortiz-Caro J, Gonzalez C, Jolin T. Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats. Endocrinology 115:2227-2232, 1984.
66. Boado R, Colombo O, Zavinovich AA. Effects of diabetes, beta hydroxybutyric acid and metabolic on pituitary-thyroid axis in the rat. J Endocrinol Invest 8:107-111, 1985.
67. Cameron O, Kronfol Z, Greden J, Carroll B. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry 41:1090-1095, 1984.
68. Roy M, Collier B, Roy A. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Res 31:31-37, 1990.
69. DeNicola AF, Fridman O, DelCastillo EJ, Foglia VG. The influence of streptozotocin diabetes on adrenal function in male rats. Horm Metab Res 8:388-392, 1976.
70. Rhees RW, Wilson CT, Heninger RW. Influence of streptozotocin diabetes and insulin therapy on plasma corticosterone levels in male rats. Horm Metab Res 15:353-354, 1983.
71. Scribner KA, Walker C-D, Cascio CS, Dallman MF. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 129:99-108, 1991.
72. Gibson MJ, DeNicola AF, Krieger DT. Streptozotocin-induced diabetes is associated with reduced immunoreactive beta-endorphin concentrations in neurointermediate pituitary lobe and with disrupted circadian periodicity of plasma corticosterone levels. Neuroendocrinology 41:64-71, 1985.
73. L'Age M, Langholz J, Fechner W, Salzmann H. Disturbances of the hypothalamo-hypophseal-adrenocortical system in the alloxan diabetic rat. Endocrinology 95:760-765, 1974.
74. DeNicola AF, Fridman O, DelCastillo EJ, Foglia VG. Abnormal regulation of adrenal function in rats with streptozotocin diabetes. Horm Metab Res 9:469-473, 1977.
75. DeNicola AF, Tornello S, Coirini H, Heller H, Orti E, White A, Marusic ET. Regulation of receptors for gluco- and mineralocorticoids. In: DeNicola A, Blaquier J, Soto RJ, Eds. Physiopathology of Hypophysial Disturbances and Disease of Reproduction. New York: Alan R. Liss, pp 61-85, 1982.
76. Joanny P, Steinberg J, Zamora AJ, Conte-Devolx B, Millet Y, Oliver C. Corticotropin-releasing factor release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine. Peptides 10:903-911, 1989.
77. Brooks DP, Nutting DF, Crofton JT, Share L. Vasopressin secretion in rats with genetic and streptozotocin-induced diabetes. Diabetes 38:54-57, 1989.
78. Christensen NJ. Catecholamines and diabetes mellitus. Diabetologia 16:211-224, 1979.
79. Hirsch BR, Shamoon H. Defective epinephrine and growth hormone responses in type I diabetes are stimulus specific. Diabetes 36:20-26, 1987.
80. Daly PA, Landsberg L. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Diabetes Care 14:240-248, 1991.
81. Astrup AV, Christensen NJ, Breum L. Reduced lasma noradenaline concentrations in simple-obese and diabetic obese patients. Clin Sci 80:53-58, 1991.
82. Cryer PE, Gerich JE. Relevance of glucose counterregulatory systems to patients with diabetes: Critical roles of glucagon and epinephrine. Diabetes Care 6:95-99, 1983.
83. Bergström B, Manhem P, Bramnert M, Lilja B, Sundkvist G. Impaired responses of plasma catecholamines to exercise in diabetic patients with abnormal heart rate reactions to tilt. Clin Physiol 9:259-267, 1989.
84. Vignati L, Cunningham LN. Exercise and diabetes. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS, Eds. Joslin's Diabetes Mellitus. Philadelphia: Lea & Febiger, pp 453-464, 1985.
85. Hendra TJ, Oughton J, Smith CC, Betteridge DJ, Yudkin JS. Platelet function in uncomplicated insulin-dependent diabetic patients at rest and following exercise. Diabet Med 5:469-173, 1988.
86. Bitar M, Koulu M, Rapoport SI, Linnoila M. Adrenal catecholamine metabolism and myocardial adrenergic receptors in streptozotocin diabetes. Biochem Pharmacol 36:1011-1016, 1987.
87. Fushimi H, Inoue T, Kishino B, Nishikawa M, Tochino Y, Funakawa S, Yamatodani A, Wada H. Abnormalities in plasma catecholamine response and tissue catecholamine accumulation in streptozotocin diabetic rats: A possible role for diabetic autonomic neuropathy. Life Sci 35:1077-1081, 1984.
88. McCovery T, Fadden C, Steger RW. Effects of streptozotocin-induced diabetes on the response of male rats to immobilization stress. Endocrine (in press), 1996.
89. Wilke RA, Riley DA, Lelkes PI, Hillard CJ. Decreased catecholamine secretion from the adrenal medullae of chronically diabetic BB-Wistar rats. Diabetes 42:862-868, 1993.
90. Brown FM, Smith AM, Longway S, Rabinowe SL. Adrenal medullitis in type I diabetes. J Clin Endocrinol Metab 71:1491-1495, 1990.
91. Tank AW, Curella P, Ham L. Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: Evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents. Mol Pharmacol 30:497-503, 1986.
92. Leland OS, Maki PC. Heart disease and diabetes mellitus. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS, Eds. Joslin's Diabetes Mellitus. Philadelphia: Lea & Febiger, pp 553-582, 1985.
93. Kozak GP, Cooppan R, Diabetes and other endocrinogic disorders. Philadelphia: Lea & Febiger, 1985.
94. Morff RJ. Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozocin-induced diabetes. Diabetes 39:354-360, 1990.
95. Rinaldi GJ, Cingolani HE. Effect of diabetes on fast response to norepinephrine in rat aorta. Diabetes 41:30-34, 1992.
96. Bartak V, Josifko M, Horackova M. Juvenile diabetes and human sperm quality. Int J Fertil 20:30-32, 1975.
97. Fairburn CG. The sexual problems of diabetic men. Br J Hosp Med 25:484-491, 1981.
98. Kolodny RC, Kahn CG, Goldstein HH, Barnett DM. Sexual dysfunction in diabetic men. Diabetes 23:306-309, 1974.
99. Johnson LM, Sidman RL. A reproductive endocrine profile in the diabetes (db) mutant mouse. Biol Reprod 20:552-559, 1979.
100. King TS, Rohrbach DH. Reduced aminergic synthesis in the hypothalamus of the infertile, genetically diabetic (C57BL/KsJ-db/db) male mouse. Exp Brain Res 81:619-625, 1990.
101. Murray FT, Cameron DF, Orth JM, Katovich MJ. Gonadal dysfunction in the spontaneously diabetic BB rat: Alterations of testes morphology, serum testosterone and LH. Horm Metab Res 17:495-501, 1985.
102. Murray FT, Orth J, Gunsalus G, Weisz J, Li JB, Jefferson LS, Musto NA, Bardin CW. The pituitary-testicular axis in the streptozotocin diabetic male rat: Evidence for gonadotroph, Sertoli cell and Leydig cell dysfunction. Int J Androl 4:265-280, 1981.
103. Steger RW, Amador A, Lam E, Rather J, Weis J, Smith MS. Streptozotocin-induced deficits in sex behavior and neuroendocrine function in male rats. Endocrinology 124:1737-1743, 1989.
104. Steger RW. Testosterone replacement fails to reverse the adverse effects of streptozotocin-induced diabetes on sexual behavior in the male rat. Pharmacol Biochem Behav 35:577-582, 1990.
105. Faerman I, Vilar O, Rivarola MA, Rosner JM, Jadzinsky MN, Fox D, Perez Lloret A, Bernstein-Hahn L, Saraceni D. Studies of androgenic function in diabetic impotent males. Diabetes 21:23-30, 1972.
106. Ficher M, Zuckerman M, Fishkin RE, Goldman A, Neeb M, Fink PJ, Cohen SN, Jacobs JA, Weisberg M. Do endocrines play an etiological role in diabetic and nondiabetic sexual dysfunctions. J Androl 5:8-16, 1984.
107. Kent JR. Gonadal function in impotent diabetic males. Diabetes 15:537, 1966.
108. Schoffling K. Hypogonadism in male diabetic subjects. In: Leibel BS, Wrenshall GA, Eds. On the Nature and Treatment of Diabetes. Amsterdam: Excerpta Medica Foundation, 1965.
109. Spark RF, White RA, Connolly PB. Impotence is not always psychogenic. JAMA 243:750-755, 1980.
110. Coiro V, Butturini U, Gnudi A, Volpe R, D'Amato L, Speroni G, Capretti L, Roti E, Choidera P. TSH and PRL response to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. Horm Res 25:206-214, 1987.
111. Distiller LA, Sagel J, Morley JE, Joffe BI, Seftel HC. Pituitary responsiveness to luteinizing hormone-releasing hormone in insulin dependent diabetes mellitus. Diabetes 24:378-380, 1975.
112. Iranmanesh A, Veldhuis JD, Carlsen EC, Vaccaro VA, Booth RA Jr., Lizarralde G, Asplin CM, Evans WS. Attenuated pulsatile release of prolactin in men with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 71:73-78, 1990.
113. Lester EVA, Woodroffe FJ, Smith RL. Prolactin and impotence in diabetes mellitus. Ann Clin Biochem 18:6-8, 1981.
114. Calvo JC, Baranao JLS, Tesone M, Charreau EH. Hypothalamic-hypophyseal-gonadal axis in the streptozotocin-induced diabetic male rat. J Steroid Biochem 20:769-772, 1984.
115. Chandrashekar V, Steger RW, Bartke A, Fadden CT, Kienast SG. Influence of diabetes on the gonadotropin response to the negative feedback effect of testosterone and hypothalamic neurotransmitter turnover in adult male rats. Neuroendocrinology 54:30-35, 1991.
116. Howland BE, Zebrowski EJ. Some effects of experimentally-induced diabetes on pituitary-testicular relationships in rats. Horm Metab Res 8:465-469, 1976.
117. Hails R, Fadden C, Steger RW. Diabetes disrupts copulatory behavior and neuroendocrine responses of male rats to female conspecifics. Pharmacol Biochem Behav 44:837-842, 1993.
118. Amador AG, Bartke A, Parkening TA, Siler-Khodr TM, Collins TJ, Stallings MH, Hogan MP, Hebert A. Hormonal regulation of testicular human chorionic gonadotropin binding and steroidogenesis in adult mice with different forms of hereditary diabetes and obesity. Horm Res 23:215, 1986.
119. Edmonds ES, Dallie SK, Withyachumnarnkul B. Reproductive system of the obese male Zucker rat. Reproductive capacity, artificial insemination and plasma testosterone levels. Biol Reprod 27:891-897, 1982.
120. Steger RW, Kienast GS. The effect of continuous versus delayed insulin replacement on sex behavior and neuroendocrine function in diabetic male rats. Diabetes 39:942-948, 1990.
121. Howland BE, Zebrowski EJ. Pituitary response to gonadotropin-releasing hormone in diabetic male rats. Experientia 36:610-611, 1980.
122. Clough RW, Steger RW, Kienast SG. Luteinizing hormine-releasing hormone (LHRH) secretion in vitro from steptozotocin-induced diabetic rat hypothalami. (abstract) Program of the 72nd Annual Mtg of the Endocrine Society 453, 1990.
123. King TS, Kang IS. Effects of chronic diabetes on in vitro GnRH release from the hypothalamus of the male rat. Biomed Res 10:333-339, 1989.
124. Djursing H, Hagen C, Nyholm H, Carstensen L, Andersen A. Gonadotropin responses to gonadotropin releasing hormone and prolactin responses to thyrotropin releasing hormone and metoclopramide in women with amenorrhes and insulin treated diabetes mellitus. J Clin Endocrinol Metab 56:1016-1021, 1983.
125. Djursing H, Nyholm H, Hagen C, Carstensen L, Pedersen L. Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus. Am J Obstet Gynecol 143:876-882, 1982.
126. Prelevic GM, Wurzburger MI, Peric A. Blunted prolactin response to metocloppramide in insulin-dependent diabetic patients with secondary ammenorrhea. Arch Gynecol Obstet 241:145-149, 1987.
127. Schickler R, Niznik CM. Sexual concerns of the female with diabetes. 33rd Prof Symp, Am Diabetes Assc, IL affiliate, 1990.
128. Schreiner-Engel P, Schiavi RC, White D, Ghizzani A. Low sexual desire in women: The role of reproductive hormones. Horm Behav 23:221-234, 1989.
129. Blades RA, Bryant KR, Whitehead SA. Feedback effects of steroids and gonatrophin control in adult rats with streptozotocin-induced diabetes mellitus. Diabetologia 28:348-354, 1985.
130. Steger RW, Kienast SG, Pillai S, Rabe M. Effects of streptozotocin-induced diabetes on neuroendocrine responses to ovariectomy and estrogen replacement in female rats. Neuroendocrinology 57:525-531, 1993.
131. Tesone M, Ladenheim RG, Cheb-Terrab R, Chiauzzi V, Solano A, Podesta E, Charreau EH. Comparison between bioactive and immunoactive luteinizing hormone (LH) in ovariectomized streptozotocin-induced diabetic rats: Response to LH-releasing hormone. Endocrinology 119:2412-2416, 1986.
132. Spindler-Vomachka M, Johnson DC. Altered hypothalamic-pituitary function in the adult female rat with streptozotocin-induced diabetes. Diabetologia 28:38-44, 1985.
133. Clayton RN, Catt KS. Regulation of pituitary gonadotropin releasing hormone receptors by gonadal hormones. Endocr Rev 2:186-209, 1981.
134. Kienast SG, Fadden C, Steger RW. Streptozotocin-induced diabetes blocks the positive feedback release of luteinizing hormone in the female rat. Brain Res Bull 32:399-405, 1993.
135. Bowton PA, Bryant KR, Whitehead SA. Feedback effects of gonadal steroids and pituitary LH-releasing hormone receptors in the streptozotocin-induced diabetic rat. Acta Endocrinol (Copenh) 111:467, 1986.
136. Moss RL. Effects of hypothalamic peptides on sex behavior in animal and man. In: Lipton MA, DiMascio A, Killam KF, Eds. Psychopharmacology: A generation of progress. New York: Raven Press, pp 431-440, 1978.
137. Pfaff DW. Luteinizing hormone-releasing factor potentiates lordosis behavior in hypophysectomized ovariectomized female rats. Science 182:1148-1149, 1973.
138. Bain PA, Shrenker P, Bartke A. The effect of luteinizing hormone releasing hormone on the copulatory behavior of hyperprolactinemic male rats. Horm Behav 21:430-439, 1987.
139. Knikoff TL, Patel KP. Alterations in brain hexokinase activity associated with streptozotocin-induced diabetes mellitus in the rat. Brain Res 522:157-160, 1990.
140. Mooradian AD. Diabetic complications of the central nervous system. Endocr Rev 9:346-356, 1988.
141. Kolta MG, Soliman KFA, Williams BB. Role of 5-hydroxytryptamine in the regulation of brain peptides in normal and diabetic rats. Horm Res 23:112-121, 1986.
142. 3H) spiroperidol binding in streptozotocin-diabetic rats. J Neurochem 40:1456-1459, 1983.
143. Sahu A, Sninsky CA, Kalra PS, Kalra SP. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198, 1990.
144. Bradshaw WG, Irskine MS, Baum MJ. Dissociation of the effects of gonadal steroids on brain serotonin metabolism and sexual behavior in the male rat. Neuroendocrinology 34:38-45, 1982.
145. Crowley WR, Zemkin FP. The neurochemical control of mating behavior. In: Adler NT, Ed. Neuroendocrinology of Reproduction: Physiology and Behavior. New York: Plenum Press, pp 451-484, 1981.
146. Fernandez-Guasti A, Ahlenius S, Hjorth S, Larson K. Separation of dopaminergic and serotonergic inhibitory mechanisms in the mediation of estrogen-induced lordosis behavior in the rat. Pharmacol Biochem Behav 27:93-98, 1987.
147. Moreines J, Kelton M, Luine VN, Pfaff DW, McEwen BS. Hypothalamic serotonin lesions unmask hormone responsiveness of lordosis behavior in adult male rats. Neuroendocrinology 47:453-458, 1988.
148. McKenzie RG, Trulson ME. Regional accumulation of tryptophan and serotonin following tryptophan loading in diabetic rats. J Neurochem 31:157-160, 1978.
149. McKenzie RG, Trulson ME. Does insulin act directly on the brain to increase tryptophan levels? J Neurochem 30:1205-1208, 1978.
150. McKenzie RG, Trulson ME. Effects of insulin and streptozotocin-inuced diabetes on brain tryptophan and serotonin metabolism. J Neurochem 30:205-211, 1978.
151. Curzon G, Fernando JCR. Drugs altering insulin secretion: Effects on plasma and brain concentrations of aromatic amino acids and on brain 5-hydroxytryptomine turnover. Br J Physiol 60:401-408, 1977.
152. Crandall EA, Gillis MA, Fernstrom JD. Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats. Endocrinology 109:310-312, 1981.
153. Mayanil CSK, Kazmi SMI, Baquer NZ. Changes in mnonoamine osidase acitivity in rat brain during alloxan diabetes. J Neurochem 38:179-183, 1982.
154. King TS, Rohrbach DH, Miller AL, Morgan WW. Reduced hypothalamic serotonin synthesis and serum luteinizing hormone levels in streptozotocin-diabetic male rats. Biomed Res 8:137-143, 1987.
155. Bitran D, Hull EM, Holmes M, Lookingland KJ. Regulation of male rat copulatory behavior by preoptic incertohypothalamic dopamine neurons. Brain Res Bull 20:323-332, 1988.
156. Steger RW, Bartke A, Bain PA, Chandrashekar V. Hyperprolactinemia disrupts neuroendocrine responses of male rats to female conspecifics. Neuroendocrinology 46:499-503, 1987.
157. Malmnas C. Effects of LSD-25, clonidine and apomorphine on copulatory behavior in male rat. Acta Physiol Scand 395(Suppl):96-116, 1973.
158. Malmnas C. Monoamine precursors and copulatory behavior in the male rat. Acta Physiol Scand 395(Suppl):96-116, 1973.
159. Simpkins JW, Kalra PS, Kalra SP. Inhibitory effects of androgens on preoptic area dopaminergic neurons in castrate rats. Neuroendocrinology 31:177-181, 1980.
160. Vierhapper H, Grubeck-Loebenstein B, Bratusch-Marrain P, Panzer S, Waldhausl W. The impact of euglycemia and hyperlycemia on stimulated pituitary hormone release in insulin-dependent diabetics. J Clin Endocrinol Metab 52:1230-1234, 1981.
161. Tesone M, Ladenheim RG, Charreau EH. Alterations in prolactin secretion in streptozotocin-induced diabetic rats. Correlation with pituitary and hypothalamus estradiol receptors. Mol Cell Endocrinol 43:135, 1985.
162. Ratner A, Pasternack LB, Weiss GK. Effect of restraint stress on prolactin and corticosterone levels in streptozotocin-induced diabetic rats. Life Sci 48:887-891, 1991.
163. Yogev L, Gottriech A, Timan B, Homonnai ZT, Paz GF. Changes in LH and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion. Life Sci 37:993-999, 1985.
164. Ikawa H, Irahara M, Matsuzaki T, Saito S, Sano T, Aono T. Impaired induction of prolactin secretion from the anterior pituitary by suckling in streptozotocin-induced diabetic rat. Acta Endocrinol (Copenh) 126:167-172, 1992.